HC Wainwright & Co. Maintains Buy on Mustang Bio, Adjusts Price Target To $2
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Joseph Pantginis maintains a Buy rating on Mustang Bio (MBIO), adjusting the price target to $2 from $25. This significant adjustment reflects a change in valuation perspective for MBIO.
May 13, 2024 | 4:29 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Mustang Bio's price target was significantly reduced to $2 from $25 by HC Wainwright & Co., though the Buy rating was maintained.
The drastic reduction in price target from $25 to $2, despite maintaining a Buy rating, suggests a significant reassessment of Mustang Bio's valuation and future prospects. This could lead to negative investor sentiment in the short term, potentially impacting the stock price negatively as the market adjusts to the new valuation.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100